{"id":"W2903023839","doi":"10.1016/j.euo.2018.11.006","title":"Cabozantinib for Progressive Metastatic Castration-resistant Prostate Cancer Following Docetaxel: Combined Analysis of Two Phase 3 Trials","year":2018,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Cabozantinib; Docetaxel; Prostate cancer; Oncology; Abiraterone acetate; Internal medicine; Enzalutamide; Hazard ratio; Mitoxantrone; Prednisone; Cancer; Urology; Confidence interval; Chemotherapy; Androgen receptor; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003824227,0.001893025,0.004722641,0.0009678773,0.0004093095,0.001630644,0.0008094411,0.001176578,0.002628329],"category_scores_gemma":[0.002612582,0.0006288586,0.004710608,0.001293048,0.0009520498,0.001199241,0.0004435779,0.00235067,0.0004888111],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001991346,"about_ca_system_score_gemma":0.002224133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002778427,"about_ca_topic_score_gemma":0.01578377,"domain_scores_codex":[0.9985791,0.0007299578,0.00008084441,0.0002060247,0.0001764224,0.0002276096],"domain_scores_gemma":[0.9984325,0.0004741036,0.0004489067,0.0001470311,0.0001240078,0.0003733764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.7770164,0.005947903,0.008221639,0.00283583,0.02302718,0.0001745997,0.0001814985,0.002635994,0.009868399,0.0002393824,0.003269223,0.1665819],"study_design_scores_gemma":[0.7259197,0.1747202,0.05705542,0.0004499001,0.02728439,0.0005464059,0.0001558212,0.001401542,0.002288776,0.0006374573,0.009377453,0.0001628563],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9358829,0.05405506,0.0009202601,0.001144545,0.0003292559,0.001984215,0.002721352,0.0001538516,0.002808658],"genre_scores_gemma":[0.9725569,0.01988106,0.001326903,0.0008506685,0.0002598716,0.0008450373,0.002762849,0.00004997115,0.001466797],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004722641,"threshold_uncertainty_score":0.02022475,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1105046009274817,"score_gpt":0.4826046893328425,"score_spread":0.3721000884053608,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}